InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Rosa-Bjorkeson Dagmar. Insider active across 2 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 7 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €46k. Activity tracked since 27 May 2021. The latest transaction was filed on 27 September 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosa-Bjorkeson Dagmar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
2,503 股@ US$20.68100.0% 占其流量Common StockSEC:0001127602-24-024682:0
5,986 股0Common StockSEC:0001127602-24-018836:0
14,766 股@ US$19.00100.0% 占其流量Common StockSEC:0001104659-23-117104:0
5,007 股0Common StockSEC:0001127602-23-019285:0
8,111 股0Common StockSEC:0001104659-23-064841:0
7,737 股0Common StockSEC:0001104659-22-065901:0
10,543 股0Common StockSEC:0001104659-21-075217:0
7 条申报中的 7 条
About Rosa-Bjorkeson Dagmar
ROSA-BJORKESON DAGMAR is a declarant and a director at Intercept Pharmaceuticals, INC. and Xencor Inc. There are 8 filings in total, and among the sampled recent filings the reported volumes are 0 EUR of buys and 46310 EUR of sells, between 2021-06-01 and 2024-10-01.
